 | ||||||||
| "weight loss" | ||||||||
| NEWS | ||||||||
Orexigen Weight loss Drug Trial Ended Due to Early Data Release On Tuesday, a study of Contrave drug was cancelled because of an unauthorized early release of data. Contrave is an antiobesity drug manufactured ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.